Trial Profile
The effect of tiotropium bromide on ventilation perfusion heterogeneity in chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2018
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Salbutamol
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Sponsors Boehringer Ingelheim
- 14 Dec 2018 Status changed from recruiting to completed.
- 11 May 2009 New trial record